DIA 2014 50th Annual Meeting "Celebrate the Past - Invent the Future"

Back to Agenda

National Strategy to Bridge the Gap Between Academic Innovation and Commercialization in Asia

Session Chair(s)

Herng-Der Chern, MD, PhD

Chief Medical Officer

Supra Integrated and Incubation Center, Taiwan

There are major funding and drug development know-how gaps in commercialization for translational research in academia. This forum will use three venture capital-like national strategies in Singapore, Korea, and Taiwan to bridge these gaps.

Learning Objective : Discuss the gaps between funding and drug development know-how for commercialization in translational medicine; Describe national strategies and measures to bridge the gap using an approach like venture capital; Compare the similarities and differences among three models in Asia - namely D3 Singapore, KDDF Korea, and SIIC Taiwan.

Speaker(s)

The Stanford SPARK Model

Daria Mochly-Rosen

Stanford University, United States

Professor, Co-Director of SPARK

Singapore's D3 Model

Louise Sarup, PhD

D3, A*STAR, Singapore

Head of Business Development and Licensing

Have an account?